Product Information
COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $3965.6440 per ML under NDC 00078063998. Its NADAC has been published 106 times since Jun 19, 2024.
Strength
150 mg/mL
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078063998
Classification
Brand
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Last Updated
1/7/2026
Active Ingredients
SECUKINUMABApproval Type
Biologic (BLA)
FDA Application
BLA125504On Market Since
1/21/2015
Pharmacological Classes
Price Statistics
The NADAC for COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES has been published 106 times since Jun 19, 2024, and over the history we have for it it has risen 10.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3965.6440 per ML |
|---|---|
| All-time high | $3965.6440 (Jun 24, 2026) |
| All-time low | $3579.9043 (Jun 19, 2024) |
| 52-week high | $3965.6440 |
| 52-week low | $3705.9163 |
| Median price | $3708.9234 |
| Average price | $3733.9271 |
| Largest weekly change | +7.0% (Jan 14, 2026) |
| Weeks tracked | 106 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES?
The current National Average Drug Acquisition Cost (NADAC) for COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES, manufactured by Novartis Pharmaceuticals Corporation, is $3965.6440 per ML (NDC 00078063998), effective Jun 24, 2026.
How has the price of COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES changed over time?
Over the history we have for it, the NADAC for COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES has risen 10.8%. It has been tracked across 106 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES?
Since Jun 19, 2024, the NADAC for COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES has ranged from a low of $3579.9043 (Jun 19, 2024) to a high of $3965.6440 (Jun 24, 2026), with a median of $3708.9234 per ML.
Are there cheaper alternatives to COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN), is $3961.2495 per ML — about 0% below COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES.
Who manufactures COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES?
COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES (NDC 00078063998) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification